MAP Pharmaceuticals, Inc. 4
4 · MAP Pharmaceuticals, Inc. · Filed Feb 16, 2010
Insider Transaction Report
Form 4
PERSEUS SOROS PARTNERS LLC
10% Owner
Transactions
- Other
Common Stock
2010-02-11−1,244,707→ 2,831,462 total(indirect: See Footnotes)
Footnotes (2)
- [F1]The securities reported herein are held for the account of Perseus-Soros BioPharmaceutical Fund, LP ("Perseus-Soros") and Perseus-Soros Partners, LLC ("Perseus-Soros Partners"). Perseus-Soros Partners is the general partner of Perseus-Soros.
- [F2]On February 11, 2010, Perseus-Soros distributed 1,250,000 shares of the Issuers Common Stock pro rata to its partners for no consideration and certain partners of Perseus-Soros have made subsequent pro rata distributions to their respective partners or members for no consideration (collectively, the "Distributions"). As a result of the Distributions, Perseus-Soros Partners now holds 5,293 shares of the Issuers Common Stock and Perseus-Soros now holds 2,826,169 shares of the Issuers Common Stock.